Some of those interactions, especially with CAXII,could be beneficial, but others may lead to nonspecific binding toother CA isozymes and staining nontumor tissues if applied at concentrationsexceeding the CAIX amount in the tumor. This evidence concerns the gene CA9 and neoplasm.